Table 2: Characteristics of the GItools discussed by participants
IDType of GItoolCountryType of organizationConditionIn or out of guidelineYear published
01IMCanadaFoundationMental healthOut2011
02PEUKFoundationDiabetesOut2010
03DMAustraliaFoundationCongestive heart diseaseOut2008
04IMAustraliaGovernmentStrokeIn2009
05DMCanadaFoundationDiabetesOut2013
06EVCanadaFoundationStrokeOut2008
07DMCanadaGovernmentHypertensionIn2008
08PEUSProfessionalHead injuryOut2013
09EVGermanyFoundationBreast cancerOut2008
10IMNetherlandsFoundationGenericOut2012
11EVAustraliaGovernmentNeonatal healthOut2011
12EVUSProfessionalProstate cancerOut2013
13IMAustraliaFoundationStrokeOut2012
14EVUKFoundationStrokeIn2010
15EVUKProfessionalSkin diseaseIn2012
16EVUSProfessionalHead injuryIn2013
17PECanadaFoundationDepressionIn2010
18PENetherlandsProfessionalPhysiotherapyOut2013
19PEDenmarkProfessionalUrethral catheterizationIn2013
20PEGermanyProfessionalStrokeOut2013
21IMAustraliaFoundationStrokeOut2011
22PEFinlandProfessionalOsteoporosisOut2008
23DMUSProfessionalLung cancerOut2013
24PEArgentinaGovernmentCeliac diseaseOut2011
25PEUSProfessionalProstate cancerOut2012
26DMUSFoundationHypertensionOut2008

Note: DM = point-of-care decision-making, EV = evaluation, IM = implementation, PE = patient engagement.